Nurtec ODT 75 MG tablet 8S
Ended Awarded Last action
- Contract number
- SPE2DR26F9CUA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,741
Award facts
- Contract value 100% obligated
- $4,740.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 7, 2026, by the Defense Logistics Agency (DLA) for the supply of NURTEC ODT 75 MG tablets in quantities of eight units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $4,740.63 and is scheduled for completion by January 8, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
This delivery order falls within the scope of DLA's medical supply chain operations, which provide essential pharmaceutical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. NURTEC ODT is a migraine treatment medication, representing the type of specialty pharmaceutical product that AmerisourceBergen supplies across multiple therapeutic domains under its comprehensive federal contract agreements. The non-set-aside award demonstrates the contractor's continued capability to meet federal procurement requirements through open competition and reflects the ongoing demand for prescription medications within the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26F9CUA?
SPE2DR26F9CUA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F9CUA worth?
The government has obligated $4,741 on SPE2DR26F9CUA.
Is contract SPE2DR26F9CUA an order under another contract?
Yes. SPE2DR26F9CUA is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9CUA competed?
The extent of competition for SPE2DR26F9CUA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award